Framatome to produce Lu-177 at Romania’s Cernavoda

November 18, 2024, 9:30AMNuclear News
Bernard Fontana (left) of Framatome and Cosmin Ghiță of Nuclearelectrica. (Photo: Framatome)

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at Cernavoda nuclear power plant in Romania. Lu-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of neuroendocrine tumors and prostate cancer.

To continue reading, log in or create a free account!

Related Articles

Nuclear's future discussed at MURR expansion

April 7, 2025, 3:05PMANS News

ANS Executive Director/CEO Craig Piercy recently spoke on nuclear power’s potential for answering today’s energy demands as part of the Distinguished Lecture Series at the University of...